Solstice Advanced Materials Inc. Q4 FY2025 earnings call

• David Sewell noted Solstice continued strong financial and operational results post-spin-off from Honeywell, with return on invested capital ~19% and net leverage 1.5 times EBITDA. Announced quarterly dividend of $0.75 per share.
• Nuclear business: Leading in US nuclear supply chain, Metropolis Works as only UF6 conversion site, backlog >$2 billion, planning 20% production increase in 2026, evaluating further expansion.
• Refrigerants and Electronic Materials segments showing growth driven by secular trends like nuclear energy, AI, data centers.

Refrigerants and Applied Solutions Segment

• 2025 net sales: $710 million, 10% year-over-year growth. Composed of 8% organic net sales growth and 2% foreign currency translation. Adjusted EBITDA: $190 million, down 25% year-over-year. Adjusted EBITDA margin: 26.8%, down 12.25 basis points.
  • Sub-segments: Refrigerants net sales up 20% to $367 million, Nuclear net sales up 39% to $111 million, Building Solutions and intermediate down 5% to $181 million, Healthcare Packaging down 25% to $52 million.

Electronic and Specialty Materials Segment

• 2025 net sales: $277 million, 4% year-over-year growth. Adjusted EBITDA: $51 million, down 4% year-over-year. Adjusted EBITDA margin: 18.4%, down two ninety-four basis points.
  • Sub-segments: Electronic Materials net sales up 19% to $112 million, Safety and Defense Solutions down 10% to $43 million, Research and Performance Chemical down 3% to $121 million.

• Full year 2026: Net sales expected between $3.9 billion and $4.1 billion, adjusted EBITDA between $975 million and $1.025 billion, adjusted diluted earnings per share between $2.45 and $2.75, and capital expenditures between $400 million and $425 million.
• 2026 Q1: Net sales expected between $935 million and $985 million, adjusted EBITDA between $235 million and $245 million, with adjusted EBITDA margin of approximately 25%.

• Nuclear loan repayments impacting 2026 revenues by approximately $30 million.
• Transitory costs, plant downtime, refrigerant product mix shifts, regulatory transitions affecting margins.

Q: John McNulty asked about nuclear platform pricing flow and capacity expansion.

A: David Sewell said nuclear spot pricing has increased, backlog through 2030 is contract-priced, and they're evaluating capacity expansion with customers and EPC partners. Tina Pierce added on double-digit earnings growth CAGR.

Q: Kevin McCarthy asked about refrigerant mix evolution and UF6 backlog.

A: David Sewell said refrigerant mix is shifting to 60% HFOs, expecting 80-20 split by 2026. David Sewell and Michael Leithead discussed backlog and loan return impact.

Q: Joshua Spector asked about UF6 pricing and EBITDA impact of loan repayment.

A: David Sewell said contract pricing is incrementally improving, and Tina Pierce mentioned backlog over $2 billion with 10% open for spot sales.

Q: Arun Viswanathan asked about refrigerants inventory and electronic materials strength.

A: David Sewell said refrigerant shortages are behind us, and David Sewell and Tina Pierce discussed electronic materials growth in leading-edge nodes, memory, and defense.

Q: Hassan Ahmed asked about capital allocation and bridge from Q1 to full year 2026.

A: David Sewell and Tina Pierce discussed transitory costs, nuclear loan repayment, and growth drivers across segments.

Q: Duffy Fischer asked about refrigerant regulatory help and data center size.

A: David Sewell and Michael Leithead discussed regulatory potential and data center growth as a rapidly growing but unsplit segment of refrigerants.